Ligand Pharmaceuticals (LGND) Earnings Date, Estimates & Call Transcripts $159.86 +0.77 (+0.48%) As of 03:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ligand Pharmaceuticals Earnings Summary Ligand Pharmaceuticals posted Q2 2025 earnings on August 7, 2025, reporting an EPS of $1.60, which topped the consensus estimate of $1.54 by $0.06. Quarterly revenue rose 14.7% year-over-year to $47.63 million, above analysts' expectations of $43.87 million. With a trailing EPS of -$4.00, Ligand Pharmaceuticals' earnings are expected to grow 114.45% next year, from $1.73 to $3.71 per share. Upcoming Q3 Earnings DateNov. 6Before Market OpensEstimatedConsensus EPS (Aug. 7) $1.54 Actual EPS (Aug. 7) $1.60 Beat By $0.06 Actual Revenue (Aug. 7) $47.63MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)LGND Upcoming EarningsLigand Pharmaceuticals' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Ligand Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ligand Pharmaceuticals and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataLGND Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LGND Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ligand Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20251$0.98$0.98$0.98Q2 20251$1.01$1.01$1.01Q3 20251$1.00$1.00$1.00 2025 3 $2.99 $2.99 $2.99 Q1 20261$1.19$1.19$1.19 Ligand Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/6/2025(Estimated)--------8/7/2025Q2 2025$1.54$1.60+$0.06$0.24$43.87M$47.63M5/8/2025Q1 2025$1.23$1.33+$0.10-$2.21$37.84M$45.33M8/6/2024Q2 2024$1.06$1.40+$0.34$4.72$33.04M$41.50M5/7/2024Q1 2024$0.83$3.84+$3.01-$3.15$27.92M$30.90M2/27/2024Q4 2023$0.24$0.79+$0.55$0.55$24.54M$28.10M11/8/2023Q3 2023$0.68$1.02+$0.34$2.16$27.22M$32.87M Ligand Pharmaceuticals Earnings - Frequently Asked Questions When is Ligand Pharmaceuticals' earnings date? Ligand Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on LGND's earnings history. What guidance has Ligand Pharmaceuticals issued on next quarter's earnings? Ligand Pharmaceuticals issued an update on its FY 2025 earnings guidance on Thursday, August, 7th. The company provided earnings per share guidance of 6.700-7.000 for the period, compared to the consensus estimate of 6.123. The company issued revenue guidance of $200.0 million-$225.0 million, compared to the consensus revenue estimate of $194.0 million. Did Ligand Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Ligand Pharmaceuticals (NASDAQ:LGND) reported $1.60 earnings per share (EPS) to beat the analysts' consensus estimate of $1.54 by $0.06. Learn more on analysts' earnings estimate vs. LGND's actual earnings. How can I listen to Ligand Pharmaceuticals' earnings conference call? The conference call for Ligand Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read Ligand Pharmaceuticals' conference call transcript? The conference call transcript for Ligand Pharmaceuticals' latest earnings report can be read online. Read Transcript How much revenue does Ligand Pharmaceuticals generate each year? Ligand Pharmaceuticals (NASDAQ:LGND) has a recorded annual revenue of $167.13 million. How much profit does Ligand Pharmaceuticals generate each year? Ligand Pharmaceuticals (NASDAQ:LGND) has a recorded net income of -$4.03 million. LGND has generated -$4.00 earnings per share over the last four quarters. What is Ligand Pharmaceuticals' EPS forecast for next year? Ligand Pharmaceuticals' earnings are expected to grow from $1.73 per share to $3.71 per share in the next year, which is a 114.45% increase. More Earnings Resources from MarketBeat Related Companies ADMA Biologics Earnings ANI Pharmaceuticals Earnings BioMarin Pharmaceutical Earnings Exelixis Earnings Exact Sciences Earnings Halozyme Therapeutics Earnings Madrigal Pharmaceuticals Earnings Repligen Earnings Ionis Pharmaceuticals Earnings Alkermes Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:LGND) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Ligand Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access